ea0092ps3-25-07 | Case Reports 2 | ETA2023
Patrizio Armando
, Viva Tommaso
, Martina Ferrari Silvia
, Elia Giusy
, Ragusa Francesca
, Rosaria Paparo Sabrina
, Antonelli Alessandro
, Fallahi Poupak
The risk of thyroid dysfunction induced by Interferon (IFN)-β1b therapy, in particular in patients having preexisting thyroid autoimmune disorders (AITD), is well known. We report a case of a 60-year-old female, with a 15-year history of euthyroid autoimmune thyroiditis and a 3-year history of Multiple Sclerosis (MS), in care for the evaluation of hyperthyroidism. The patient started a specific immunomodulant IFN-β1a therapy (30 μg/week) twenty months before the...